echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Popular Keywords > Keyword List D > discovery path

    discovery path

    Echemi.com offers a wide variety of articles about discovery path, easily find your discovery path information here online.
    • Save migraines! The path to discovery of CGRP inhibitors

      Time of Update: 2020-11-06
      , CGRP targeted drugs used to treat acute migraine attacks appear to cause only minor side effects such as constipation in a small number of people. , for example, CGRP antibodies are used to prevent migraine attacks, gepant is used to treat acute seizures, is there a drug that can balance two effects?
    • From snake venom to antihypertensive drug, the path to discovery of the classic drug Cattoply.

      Time of Update: 2020-08-09
      catopile (commodity name Captopril) is the first generation of oral ACEI, which originally originated from the Brazilian snake venom in a slow-motion peptide, can effectively treat a variety of primary hypertension, with rapid effect, smooth pressure reduction, long-term efficacy outstanding and other advantages, while heart failure and diabetes, kidney disease also has a good therapeutic effect.
    • From snake venom to antihypertensive drug, the path to discovery of the classic drug Cattoply.

      Time of Update: 2020-08-02
      Catopuri (commodity name Captopril) is the first generation of oral ACEI, which originally originated from the Brazilian snake venom in a slow-motion peptide, can effectively treat a variety of primary hypertension, with rapid effect, smooth blood pressure, long-term efficacy and other advantages, while heart failure and diabetes, kidney disease also has a good therapeutic effect.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.